PMC.F 122 (+2.52%)
AU000000PME8Healthcare Providers & ServicesHealth Information Services

Pro Medicus (PMC.F) Stock Highlights

122 | +2.52%
2024-10-21 23:41:48
Pro Medicus is a healthcare IT company specialising in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Statistics

Range Today
119 122
Volume Today 17
Range 1 Year
43.6 119
Volume 1 Year 11.51K
Range 3 Year
24.8 119
Volume 3 Year 25.48K
Range 10 Year
3.11 119
Volume 10 Year 164.03K

Highlights

Market Capitalization 13.47B (large)
Floating Shares 50.96M
Current Price 122
Price To Earnings 245.83
Price To Revenue 76
Price To Book 66.18
Earnings Per Share 0.48
Dividend Yield 0.23%
Dividend Per Share 0.27
Payout Ratio 44.25%

Performance

Latest +2.52%
1 Month +14.02%
3 Months +52.5%
6 Months +98.37%
1 Year +162.93%
3 Years +258.82%
5 Years +538.74%
10 Years +2859.73%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.